Literature DB >> 9013027

Tyrosine hydroxylase-containing neurons in the spinal cord of the chicken. I. Development and analysis of catecholamine synthesis capabilities.

J A Wallace1, A A Romero, A M Gabaldon, V A Roe, S L Saavedra, J Lobner.   

Abstract

1. The development of tyrosine hydroxylase-immunoreactive (TH-IR) neurons was examined in the spinal cord of the chick embryo and hatchling. 2. Two groups of TH-IR cells are described, both of which appear to reach their full complement in number relatively late in embryonic development. One group is comprised of numerous cells located ventral to the central canal which make direct contact with the lumen of the canal. The other group consists of large multipolar neurons that reside in the dorsal horn, more commonly along the outer margin of the gray matter within lamina I and II, and less frequently deeper in the dorsal horn within medial portions of laminae V, VI or VII. 3. TH-IR cells ventral to the central canal in the chick are comparable in location to dopamine (DA)-containing spinal cord cells in lower vertebrate species. In contrast, the dorsally-suited TH-IR cells in the chick are known only to occur in similar positions in higher vertebrates. Therefore, the chick is novel in that the presence of both groups of TH-IR cells appearing together in significant numbers within the spinal cord has not been shown in any other species studied to date. 4. The TH-containing cells in the chick cord do not appear to contain the catecholamine biosynthesis enzymes, DBH or PNMT. Moreover, using anti-DA immunocytochemistry, neither group of TH-IR cells demonstrated detectable levels of DA in control animals nor in animals pretreated with inhibitors of MAO (MAO-I). 5. However, a difference was noted though between the two TH-IR cell groups in terms of their responses to exogenously supplied L-DOPA, the immediate precursor to DA. With the administration of L-DOPA and a MAO-I to chick hatchlings, cells in the region ventral to the central canal stained intensely for DA. In contrast, the same treatment failed to produce DA-immunoreactive cells in the dorsal horn. 6. One reasonable hypothesis for these results is that the TH-IR cells ventral to the central canal contain an active form of AADC, the enzyme that converts L-DOPA to DA. With this interpretation, if these cells can produce DA from L-DOPA, yet do not appear to synthesize DA endogenously, it would appear that the TH enzyme contained in these cells occurs in an inactive form. Whether the TH enzyme in the dorsally located immunoreactive cells is also inactive is uncertain since it remains unclear whether they contain AADC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9013027     DOI: 10.1007/bf02151901

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  49 in total

1.  A series of normal stages in the development of the chick embryo.

Authors:  V HAMBURGER; H L HAMILTON
Journal:  J Morphol       Date:  1951-01       Impact factor: 1.804

Review 2.  Biogenic monoamines in the cyclostome and lower vertebrate brain.

Authors:  H G Baumgarten
Journal:  Prog Histochem Cytochem       Date:  1972

3.  Presence of monoaminergic neurons in the spinal cord and intestine of the lamprey, Lampetra japonica.

Authors:  S Honma
Journal:  Arch Histol Jpn       Date:  1970-11

4.  Immunohistochemical study of tyrosine-hydroxylase-positive cells and fibers in the chicken spinal cord.

Authors:  N Okado; R Ishihara; R Ito; S Homma; K Kohno
Journal:  Neurosci Res       Date:  1991-07       Impact factor: 3.304

5.  Comparative analysis of dopamine and tyrosine hydroxylase immunoreactivities in the brain of two amphibians, the anuran Rana ridibunda and the urodele Pleurodeles waltlii.

Authors:  A Gonzalez; W J Smeets
Journal:  J Comp Neurol       Date:  1991-01-15       Impact factor: 3.215

6.  Immunocytochemical analysis of the dopamine system in the brain and spinal cord of the European eel, Anguilla anguilla.

Authors:  B L Roberts; G E Meredith; S Maslam
Journal:  Anat Embryol (Berl)       Date:  1989

7.  Immunohistochemical demonstration of catecholaminergic cell bodies in the spinal cord of the rat. Preliminary note.

Authors:  M Dietl; M Arluison; P Mouchet; C Feuerstein; M Manier; J Thibault
Journal:  Histochemistry       Date:  1985

8.  Aromatic L-amino acid decarboxylase-immunoreactive neurons in and around the cerebrospinal fluid-contacting neurons of the central canal do not contain dopamine or serotonin in the mouse and rat spinal cord.

Authors:  I Nagatsu; M Sakai; M Yoshida; T Nagatsu
Journal:  Brain Res       Date:  1988-12-13       Impact factor: 3.252

9.  Distribution of aminergic neurons in the brain of the sterlet, Acipenser ruthenus (Chondrostei, Actinopterygii).

Authors:  K Kotrschal; W D Krautgartner; H Adam
Journal:  J Hirnforsch       Date:  1985

10.  Are putative dopamine-accumulating cell bodies in the hypothalamic periventricular organ a primitive brain character of non-mammalian vertebrates?

Authors:  W J Smeets; A Gonzalez
Journal:  Neurosci Lett       Date:  1990-07-13       Impact factor: 3.046

View more
  3 in total

1.  Prenatal alcohol exposure potentiates chronic neuropathic pain, spinal glial and immune cell activation and alters sciatic nerve and DRG cytokine levels.

Authors:  Shahani Noor; Joshua J Sanchez; Arden G Vanderwall; Melody S Sun; Jessie R Maxwell; Suzy Davies; Lauren L Jantzie; Timothy R Petersen; Daniel D Savage; Erin D Milligan
Journal:  Brain Behav Immun       Date:  2016-12-20       Impact factor: 7.217

2.  Immunofluorescent spectral analysis reveals the intrathecal cannabinoid agonist, AM1241, produces spinal anti-inflammatory cytokine responses in neuropathic rats exhibiting relief from allodynia.

Authors:  Jenny L Wilkerson; Katherine R Gentry; Ellen C Dengler; James A Wallace; Audra A Kerwin; Megan N Kuhn; Alexander M Zvonok; Ganesh A Thakur; Alexandros Makriyannis; Erin D Milligan
Journal:  Brain Behav       Date:  2012-03       Impact factor: 2.708

3.  Improvement of spinal non-viral IL-10 gene delivery by D-mannose as a transgene adjuvant to control chronic neuropathic pain.

Authors:  Ellen C Dengler; Lauren A Alberti; Brandi N Bowman; Audra A Kerwin; Jenny L Wilkerson; Daniel R Moezzi; Eugene Limanovich; James A Wallace; Erin D Milligan
Journal:  J Neuroinflammation       Date:  2014-05-21       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.